Stocks · News reference
STAAR Surgical Appoints Warren Foust As President And CEO, Effective August 4; Names Deborah Andrews EVP And CFO
Deborah Andrews appointed Executive Vice President and Chief Financial OfficerSTAAR Surgical Company ("STAAR" or the "Company") (NASDAQ:STAA), the global leader in phakic IOLs with the EVO family of
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $28
Stifel analyst Thomas Stephan maintains Staar Surgical (NASDAQ:STAA) with a Hold and lowers the price target from $31 to $28.
UBS Maintains Sell on Staar Surgical, Lowers Price Target to $19
UBS analyst Patrick Wood maintains Staar Surgical (NASDAQ:STAA) with a Sell and lowers the price target from $20 to $19.
Wedbush Maintains Outperform on Staar Surgical, Lowers Price Target to $37
Wedbush analyst Michael Piccolo maintains Staar Surgical (NASDAQ:STAA) with a Outperform and lowers the price target from $40 to $37.